FDA — authorised 12 October 2023
- Application: NDA216956
- Marketing authorisation holder: PFIZER
- Local brand name: VELSIPITY
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Velsipity in United States
FDA authorised Velsipity on 12 October 2023
Marketing authorisations
FDA
- Marketing authorisation holder: PFIZER
- Status: approved
Velsipity in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Velsipity approved in United States?
Yes. FDA authorised it on 12 October 2023; FDA has authorised it.
Who is the marketing authorisation holder for Velsipity in United States?
PFIZER holds the US marketing authorisation.